Fierce Pharma Asia—Sun's price-fixing settlement; Eisai's coverage win; AstraZeneca's India layoffs,Sun Pharma chose to...
lecanemab
Alzheimer's Association campaigns for broader Leqembi coverage: report,After CMS slapped down a petition for...
Biogen's new CEO Chris Viehbacher looks to ads, patient outreach to boost promotion of...
Fierce Pharma Asia—Samsung's deal with Pfizer; Olympus' and Dr. Reddy's M&A moves; BeiGene's growth,Pfizer...
CMS restricts coverage of amyloid-targeting Alzheimer's antibodies,CMS has denied the Alzheimer's Association's request asking...
Lecanemab: Experimental drug is a ray of hope for Alzheimer’sdisease,An 18-month treatment with lecanemab...
What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those...
Lecanemab: US FDA approves new ‘breakthrough’ medicine for Alzheimer’s,The US Food and Drug Administration...
